Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Global Generative AI in Pharmaceutical Market Outlook
4.1. Market Size & Forecast
4.1.1. By Value
4.2. Market Share & Forecast
4.2.1. By Drug Type (Small Molecule, Large Molecule)
4.2.2. By Application (Clinical Trial Research, Drug Discovery, Research And Development, Others)
4.2.3. By Technology (Deep Learning, Natural Language Processing, Querying Method, Context-aware Processing, Others)
4.2.4. By Region
4.2.5. By Company (2022)
4.3. Market Map
4.3.1. By Drug Type
4.3.2. By Application
4.3.3. By Technology
4.3.4. By Region
5. Asia Pacific Generative AI in Pharmaceutical Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Drug Type
5.2.2. By Application
5.2.3. By Technology
5.2.4. By Country
5.3. Asia Pacific: Country Analysis
5.3.1. China Generative AI in Pharmaceutical Market Outlook
5.3.1.1. Market Size & Forecast
5.3.1.1.1. By Value
5.3.1.2. Market Share & Forecast
5.3.1.2.1. By Drug Type
5.3.1.2.2. By Application
5.3.1.2.3. By Technology
5.3.2. India Generative AI in Pharmaceutical Market Outlook
5.3.2.1. Market Size & Forecast
5.3.2.1.1. By Value
5.3.2.2. Market Share & Forecast
5.3.2.2.1. By Drug Type
5.3.2.2.2. By Application
5.3.2.2.3. By Technology
5.3.3. Australia Generative AI in Pharmaceutical Market Outlook
5.3.3.1. Market Size & Forecast
5.3.3.1.1. By Value
5.3.3.2. Market Share & Forecast
5.3.3.2.1. By Drug Type
5.3.3.2.2. By Application
5.3.3.2.3. By Technology
5.3.4. Japan Generative AI in Pharmaceutical Market Outlook
5.3.4.1. Market Size & Forecast
5.3.4.1.1. By Value
5.3.4.2. Market Share & Forecast
5.3.4.2.1. By Drug Type
5.3.4.2.2. By Application
5.3.4.2.3. By Technology
5.3.5. South Korea Generative AI in Pharmaceutical Market Outlook
5.3.5.1. Market Size & Forecast
5.3.5.1.1. By Value
5.3.5.2. Market Share & Forecast
5.3.5.2.1. By Drug Type
5.3.5.2.2. By Application
5.3.5.2.3. By Technology
6. Europe Generative AI in Pharmaceutical Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drug Type
6.2.2. By Application
6.2.3. By Technology
6.2.4. By Country
6.3. Europe: Country Analysis
6.3.1. France Generative AI in Pharmaceutical Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Drug Type
6.3.1.2.2. By Application
6.3.1.2.3. By Technology
6.3.2. Germany Generative AI in Pharmaceutical Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Drug Type
6.3.2.2.2. By Application
6.3.2.2.3. By Technology
6.3.3. Spain Generative AI in Pharmaceutical Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Drug Type
6.3.3.2.2. By Application
6.3.3.2.3. By Technology
6.3.4. Italy Generative AI in Pharmaceutical Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Drug Type
6.3.4.2.2. By Application
6.3.4.2.3. By Technology
6.3.5. United Kingdom Generative AI in Pharmaceutical Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Drug Type
6.3.5.2.2. By Application
6.3.5.2.3. By Technology
7. North America Generative AI in Pharmaceutical Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Drug Type
7.2.2. By Application
7.2.3. By Technology
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States Generative AI in Pharmaceutical Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Drug Type
7.3.1.2.2. By Application
7.3.1.2.3. By Technology
7.3.2. Mexico Generative AI in Pharmaceutical Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Drug Type
7.3.2.2.2. By Application
7.3.2.2.3. By Technology
7.3.3. Canada Generative AI in Pharmaceutical Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Drug Type
7.3.3.2.2. By Application
7.3.3.2.3. By Technology
8. South America Generative AI in Pharmaceutical Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Drug Type
8.2.2. By Application
8.2.3. By Technology
8.2.4. By Country
8.3. South America: Country Analysis
8.3.1. Brazil Generative AI in Pharmaceutical Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Drug Type
8.3.1.2.2. By Application
8.3.1.2.3. By Technology
8.3.2. Argentina Generative AI in Pharmaceutical Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Drug Type
8.3.2.2.2. By Application
8.3.2.2.3. By Technology
8.3.3. Colombia Generative AI in Pharmaceutical Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Drug Type
8.3.3.2.2. By Application
8.3.3.2.3. By Technology
9. Middle East and Africa Generative AI in Pharmaceutical Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Drug Type
9.2.2. By Application
9.2.3. By Technology
9.2.4. By Country
9.3. MEA: Country Analysis
9.3.1. South Africa Generative AI in Pharmaceutical Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Drug Type
9.3.1.2.2. By Application
9.3.1.2.3. By Technology
9.3.2. Saudi Arabia Generative AI in Pharmaceutical Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Drug Type
9.3.2.2.2. By Application
9.3.2.2.3. By Technology
9.3.3. UAE Generative AI in Pharmaceutical Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Drug Type
9.3.3.2.2. By Application
9.3.3.2.3. By Technology
9.3.4. Egypt Generative AI in Pharmaceutical Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Drug Type
9.3.4.2.2. By Application
9.3.4.2.3. By Technology
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
11.1. Recent Developments
11.2. Product Launches
11.3. Mergers & Acquisitions
12. Global Generative AI in Pharmaceutical Market: SWOT Analysis
13. Porter?s Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Product
13.6.
14. Competitive Landscape
14.1. AstraZeneca Plc
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products & Services
14.1.4. Current Capacity Analysis
14.1.5. Financials (In case of listed)
14.1.6. Recent Developments
14.1.7. SWOT Analysis
14.2. Nvidia
14.3. Baidu
14.4. Johnson & Johnson
14.5. Sanofi
14.6. Adaptyv Bio
15. Strategic Recommendations
16. About Us & Disclaimer